The Correlation between Clumping Factor A Gene Expression in Biofilm Formation and Antibiotic Resistance Among Staphylococcus aureus Isolated from Urine Samples of Imam Khomeini Hospital, Tehran

نویسندگان
doi
10.18502/jabs.v13i3.13223
چکیده

Background & Objective: Staphylococcus aureus causes problems in hospitals and it has emerged as a serious agent acquired from the environment in recent years. One of the capabilities of S. aureus is the formation of biofilms, in which bacteria can exchange antibiotic-resistance genes among themselves and increase the virulence of other strains of this species ( S. aureus ). A surface protein attached to the cell wall in S. aureus clumping factor A is a virulence factor in various staphylococcal infections. Materials & Methods: In this study, after the Urea Analysis (UA) test, the urea culture test was applied to the blood agar and Baird-Parker Agar culture media from the infectious urine samples in Imam Hospital, Tehran, to identify S. aureus isolates. Finally, a molecular method was used for the confirmation of identified isolates. The microliter plate method was performed to determine the biofilm formation ability . The disk diffusion method was also used for profiling the antibiotic resistance of the isolates. Results: In the results of this study, 45 out of 160 urinary clinical samples were positive for S. aureu s , among which 42 isolates expressed the clfA gene. Moreover, 39 isolates had the ability to form biofilms in vitro. Among these 42 isolates, the highest (88%) and the lowest (16%) rates of antibiotic resistance were observed against penicillin and cefoxitin, respectively. Data analysis with SPSS software and chi-square indicated a significant relationship between gene expression and biofilm production with antibiotic resistance (P < 0.05). Conclusion: The resistance of S. aureus bacteria is increasing strongly due to the repeated use of antibiotics such as beta-lactams, especially in respiratory infections and pharyngitis. Moreover, biofilm formation and virulence factors, such as clfA and clfB , cause concerns to the World Health Organization for treatment, especially for people with sepsis or toxemia.